Finding the right people for the right job might seem an afterthought for big Pharma companies that have cut their US workforce by more than 250,000 in the past 10 years.
Mexico and other emerging markets top the skills gap list
By Susan Crowley
Finding the right people for the right job might seem an afterthought for big Pharma companies that have cut their US workforce by more than 250,000 in the past 10 years. But the rush is back on for talent: the challenge is making sense of what skills and capabilities will be needed to improve the productivity of human capital as the industry adjusts to a new, more global competitive climate. The Healthcare Businesswoman’s Association [HBA] is making an effort to answer this question, and organized a dinner symposium on Tuesday in the industry’s jobs heartland – New Jersey – around the theme, “Pharma 2015: What talents will be required to remain competitive in the future?”
Participants discussed a survey prepared by the outplacement consultant Right Management based on extensive interviews with 15 top pharma companies covering their future talent requirements and to identify the links between proper staffing and achieving consistent gains in innovation, profitability and competitiveness. The survey findings show that successful organizations that lead in these three areas share a common bond: higher rates of employee retention and a reputation as a place where people want to work, compared to other companies. Executives identified as a talent “constraint” the fact that pay and benefits for the top candidates are trending higher for mid-rank positions and above, and that a shortage of applicants with specific skills make it more difficult to innovate in certain areas and to pursue particular markets or opportunities.
An interesting aspect of the survey was the designation of country markets with the biggest mismatch between company needs and the availability of talent. Mexico came out on top, followed by Brazil, India, China, South Korea, Australia and the US. The easy conclusion is that growth in the emerging country market will slow unless the skills gap is breached. Alternatively, the message might be – if you want a good job in the industry, point your compass to the east and south.
The survey and discussion also revealed how important it is to demonstrate the capacity to participate effectively across functions and cultures and to lead teams. Right Management executive Robin Guarnieri stated that in 1985, fully 75% of knowledge required to carry out a pharmaceutical industry job function was vested in the individual worker; by 2009, only 8-10% of the knowledge required in a job was retained by an individual. A result of this trend is that the retained knowledge of a staff member is no longer the differentiator for success – leveraging knowledge to win business requires a culture of collaboration – the cliché is now truth.
Any comments?
Susan Crowley is principal of Multilateral Consulting LLC. She can be reached at scrowley@multilateralconsulting.com
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.